Plus de 1 500 auteurs et chercheurs provenant de plus de 27 pays
David Ackerley is a professor of biotechnology at the School of Biological Sciences (Victoria University of Wellington). He is a microbiologist and enzyme engineer, with a primary focus on discovery, characterisation, engineering and application of useful bacterial enzymes, and of novel antibiotics to counter the spread of multi-drug resistant bacteria.
CASE STUDY. This decision-based case focuses on whether Proacta should raise more funds within New Zealand alone, syndicate a venture capital round with international investors, or seek a trade sale of the company.